CDMO Intelligence

NEW 2023: CDMO Intelligence Transform your decision making with comprehensive market landscape insight

Effective decision-making can make or break your success. CDMO Intelligence is your secret weapon in that decision making process. Access CDMO screening, molecular landscape insights, detailed manufacturing capabilities, and accurate volume forecasts. You’ll have a wealth of data and industry insights at your fingertips, backed by gold standard financial forecast methodologies. With our trusted CDMO Intelligence platform, you’ll identify potential risks and mitigate them effectively to maximise your success.

Speak to our team

CDMO Screener

Gain insights into the market size by technology type/subtype. Identify leading CDMOs in each technology area and assess consensus forecasts for drugs manufactured by CDMOs.

Molecular Landscape

Obtain competitive intelligence insights. Identify specific CDMOs based on service offering, location, and molecule focus. Analyse CDMO facilities and service offerings to assess strengths and weaknesses. Explore the drugs manufactured by a CDMO and their production sites.

Business Development Insights

Understand which CDMO a pharma company currently uses for drug manufacturing. Identify early-stage pipeline drugs for business development purposes. Identify white spaces and potential partners. PTRS and peak sales for CDMO-developed drugs.

Enhanced Due Diligence

Gain an objective view of the CDMO landscape and market size. Understand market dynamics and ROI potential for CDMO investments. Assess CDMO portfolios and associated product commercial potential. Evaluate CDMO capacity and future demand for informed investment decisions.

Volume Forecasting

Understand the demand for manufacturing specific drugs by kilogram. Identify drugs with growing demand. Profile key account needs for manufacturing. Inform pricing strategy and investment in new capabilities or facilities.

Contact Finder

Finding the right people within potential partner organisations can be like finding a needle in a haystack. That’s where our Contact Finder comes in. It aids in connecting you with senior-level decision-makers, facilitating crucial partnerships and collaborations.

Find out more

CDMO FINANCES CONSULTING PHARMA

Why choose us

With CDMO Intelligence, you’ll identify potential risks and make well-informed decisions to maximize your success.
Our tool empowers you to:

Develop effective strategies backed by trusted data:
Our solution is built on reliable and comprehensive data, ensuring that your strategy is validated ensuring you act on reliable information.

Assess future market potential and untapped opportunities:
By leveraging our solution, you gain insights into the potential of the market and can identify unexplored opportunities.

Understand competitors and stay ahead:
Stay ahead of the competition by staying informed. CDMO Intelligence equips you with the competitive intelligence you need

Streamline decision-making process and save time:
With CDMO Intelligence, you can streamline your decision-making process. Spend less time searching for information and more time making impactful decisions.

Speak to our team today

Ready to take your CDMO decision-making to the next level?

Contact our team today to learn more about the transformative benefits of CDMO Intelligence.
Strategically target opportunities poised to deliver the best ROI.

Related content

CDMO Focus: Three Areas to Drive Success

CDMOs (Contract Development and Manufacturing Organisations) are key players in the biopharma market, playing a vital role in translating science into medicines that change people’s lives. Almost all pharma and biotech companies rely on CDMO services to some extent, whether that’s for clinical trials or huge marketed drugs. However, CDMOs view the market through a different lens to their partners in the drug development world, focusing on technology rather than indication. This leads to a unique challenge for those tasked with long-term strategy. It means that planning requires more than a clear view of the R&D pipeline, cutting-edge technologies and patient populations – the clients’ world. It also needs an understanding of the wider CDMO landscape and their specific position in it.

Click to read

Report: World Preview 2023

The pharmaceutical sector is entering new and unfamiliar territory. Key assumptions, such as the unrivalled profitability of the US market and the reliance on large M&A to spur growth, are getting a serious shake-up.

From the FDA's shifting temperament and the ripple effects of the IRA, commercial disruptions, dealmaking ambiguities and breakthroughs in R&D, we've identified five critical forces that are converging to reshape the pharma and biotech landscape.

Explore the Evaluate World Preview 2023 now for an in-depth analysis of the landscape out to 2028 – and answers to the questions that everyone in the industry is asking.

Click to read